MacroGenics, Inc. (NASDAQ: MGNX), a biopharmaceutical company focused on developing and commercializing innovative antibody-based therapeutics for the treatment of cancer, today announced the …
https://finance.yahoo.com/news/macrogenics-announces-appointment-william-heiden-200100686.html